Literature DB >> 6367935

Giant lymph node hyperplasia with unusual clinicopathologic features.

W C Chan, H Hargreaves, J Keller.   

Abstract

This report describes two cases of giant lymph node hyperplasia (GLNH) with unusual clinicopathologic features, both studied with immunohistochemical techniques. In the first case, mesenteric GLNH was associated with amyloidosis and the nephrotic syndrome. In the second, GLNH developed in a patient with previously treated Hodgkin's disease. In both cases, the GLNH was of the plasma cell variant. The plasma cells of the first case contained both kappa and lambda light chains, while those in the second case contained only the lambda light chain. The presence or absence of monoclonality was not predictable from the morphology alone. Cases of GLNH with unusual clinicopathologic features are reviewed and the significance of immunohistochemical studies discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6367935     DOI: 10.1002/1097-0142(19840515)53:10<2135::aid-cncr2820531024>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Castleman disease with renal amyloidosis: imaging findings and clinical significance.

Authors:  W K Moon; S H Kim; J G Im; K M Yeon; M C Han
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

2.  Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.

Authors:  S Ikeda; H Chisuwa; S Kawasaki; J Ozawa; Y Hoshii; T Yokota; T Aoi
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

3.  Angiofollicular lymph node hyperplasia with amyloidosis.

Authors:  K P West; D R Morgan; I Lauder
Journal:  Postgrad Med J       Date:  1989-02       Impact factor: 2.401

4.  Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus.

Authors:  C A Hanson; G Frizzera; D F Patton; B A Peterson; K L McClain; K J Gajl-Peczalska; J H Kersey
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

5.  Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).

Authors:  C Aktolun; H Bayhan; B Celasun; M K Kir
Journal:  Eur J Nucl Med       Date:  1991

Review 6.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.